Abstract
Evaluating the Safety and Immunogenicity of HIV-1 BG505 SOSIP.664 gp140 With TLR Agonist and/or Alum Adjuvants in Healthy, HIV-uninfected Adults
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have